Today’s articles on Sectors

Boeing - One Letter That Tells It All By Dhierin Bechai • 12 comments High Dividend Stock Has 47 Straight Dividend Hikes, Good Cash Flow And EPS Growth By Double Dividend Stocks • 6 comments Bank Of America Is A Buy Ahead Of Rate Hike By Achilles Research • 30 comments Editors' Picks Buy Land, They Ain't Making Any More Of The Stuff By Brad Thomas Hate The Game, Not The Player? - Mylan Is Out Of Tune Amid An Angry Chorus By Dr. Duru Abbott Is Still A Steady Eddie, But I Wouldn't Buy Now By From Growth to Value Want To Know The Future Of Herbalife And Other MLMs? Look No Further Than The Facts By William Keep Alpha From Equal-Weighting: Industrials And Conclusions By Ploutos More Editors' Picks» Basic Materials Kinross Gold - Commentary On The Recent Operational Updates by Fun Trading Best Of Breed Stocks: Helmerich & Payne by Leo Nelissen Chesapeake Energy Makes Another Astute Decision by Orthodox Investor Seadrill Partners - All You Need To Know About The Q2 2016 Results by Fun Trading Learn And Adjust - Key Learnings From Following VAR Models by Brian Auty More Basic Materials» Consumer Goods Altria Raises Dividend, But What's Next? by Bill Maurer Sony's High-End Bridge Cameras Are Also A Threat To Canon And Nikon by Motek Moyen J.M. Smucker: Staying On The Sidelines For Now by The Value Investor The Energizer Opportunity Revisited by Robert Altabet Crown Crafts: Like Taking Money From A Baby by Aspis Research More Consumer Goods» Financial The Potential Coming Bank Of America Mega-Crash And How To Hedge Against It While Still Generating Solid Income by Dividend Sensei 100% Of The GSEs For Zero Consideration Is Great For Tax Collectors by Glen Bradford BOFI: Will The FDIC Stop The Music? by Aurelius Stone Harbor Emerging Markets Total Income Fund: A Good Or Bad Investment? by Norman Roberts How Bloomberg's 'Expose' On LendingClub Is Wrong by Stephen Zentner More Financial» Healthcare Antares Pharmaceuticals: The Stock To Buy On EpiPen Issues by Alexander Maxwell Momenta Has Momentum After Recent Patent Decision by Alexander Maxwell Stemline Therapeutics: A Biotech Comeback Story by Jonathan Faison Why Recent Fanapt Ruling Is Important To Vanda by Alexander Maxwell Vertex Pharmaceuticals Should Earn An Expanded Label For Its Lead Blockbuster Drug by Clinically Sound Investor More Healthcare» Industrial Goods What To Make Of Chicago Bridge & Iron's Move by Daniel Jones Beazer Homes USA: Don't Be Fooled By Its Incredibly Cheap Outlook by Harm Elderman More Industrial Goods» Services Why Sirius XM Will Redeem Debt by Crunching Numbers Whole Foods Market: So What Really Drives This Stock Down All The Time? by Harm Elderman GameStop: Value Or Value Trap by Chris Lau Genuine Parts Company: Two Reasons Not To Like It by Josh Arnold Is Zoe's Kitchen Still Overvalued by Andrew Mackler More Services» Technology The Mystery Of Pure Storage's Earnings: When A Good Quarter Is Not A Good Quarter by Totoro Research Why The Solar Industry's Struggles Will Persist by Quinn Foley Qualcomm: 25% Upside Coming by Nikhil Gupta Splunk: You Really Need A Scorecard To Tell Who's On First by Bert Hochfeld 2Q 2016's S&P 500 Results (Aug 26, 1916): Tactical, Economic, S&P Earnings And Stock Market Internals Will Lead Stock Markets by Joe Eqcome More Technology» Utilities Dominion Resources: Sell High And Buy Low by Bull's Run A Closer Look At Suburban Propane Partners' 3rd Fiscal Quarter's Results by Ron Hiram Otter Tail Corporation: Leaving Dividend Growth To The Wind by Jenks Jumps More Utilities» Please do not forward this email. It allows direct access to your Seeking Alpha Portfolio. Why are you receiving this? You subscribed to Sectors at Seeking Alpha. Unsubscribe from this email or manage all your Seeking Alpha email choices here. To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders. Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017